Cue Biopharma, Inc.CUENASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank30
3Y CAGR-84.2%
5Y CAGR-70.2%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-84.2%/yr
vs -3.7%/yr prior
5Y CAGR
-70.2%/yr
Recent deceleration
Acceleration
-80.6pp
Decelerating
Percentile
P30
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.22 | -95.8% |
| 2024 | 5.15 | -67.5% |
| 2023 | 15.84 | -71.5% |
| 2022 | 55.66 | +175.9% |
| 2021 | 20.18 | -78.1% |
| 2020 | 92.31 | +2.5% |
| 2019 | 90.05 | +39.4% |
| 2018 | 64.62 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |